Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Eculizumab for Pediatric Hematopoietic Cell Transplant-Associated Thrombotic Microangiopathy: Real-World Response Rates, Predictors of Poor Response, and an Optimal Time Point for Treatment Response Assessment.
Journal: Transplantation and cellular therapy
Published: March 24, 2026
Safety and feasibility of umbilical cord blood transplantation in children with neuronal ceroid lipofuscinosis: a retrospective study.
Journal: Stem cells translational medicine
Published: May 31, 2024
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependency.
Journal: The Journal of clinical investigation
Published: September 05, 2023
CD34 Stem Cell Boost in Pediatric Allogeneic Stem Cell Transplant Recipients: A Case Series and Review of Literature.
Journal: Clinical hematology international
Published: November 26, 2022
Peritoneal and Pleural Drains in Pediatric Hematopoietic Cell Transplant Recipients with Veno-Occlusive Disease are Safe and Do Not Adversely Impact Clinical Outcomes.
Journal: Hematology/oncology and stem cell therapy
Published: June 25, 2022
Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus.
Journal: Pediatric nephrology (Berlin, Germany)
Published: October 13, 2021
Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes.
Journal: Transplantation and cellular therapy
Published: October 01, 2021
Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
Journal: Case reports in rheumatology
Published: April 07, 2021
Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation.
Journal: Pediatric transplantation
Published: November 30, 2020
Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late-onset primary isolated central nervous system hemophagocytic lymphohistiocytosis.
Journal: Pediatric transplantation
Published: November 22, 2017
Last Updated: 09/26/2026